Spectral Medical Inc. announced the appointment of Chris Seto to Chief Executive Officer, effective April 1, 2021. In his new role, Mr. Seto will continue to serve as the Company’s Chief Financial Officer (“CFO”). Dr. Paul Walker, current CEO, will remain committed to the Company as a member of the Board of Directors, where he will be responsible for a seamless transition of leadership, and focus his efforts on the Tigris Trial supporting Dr. John Kellum, Spectral’s recently announced Chief Medical Officer. Previously, Mr. Seto was responsible for overseeing the financial and operational management of the Company including, finance, accounting, treasury and capital markets, as well as corporate planning and development, and investor relations. Prior to joining Spectral Medical, Mr. Seto was the CFO of MJardin Group Inc. and GrowForce Holdings Inc.